Costs and complications of extracorporeal membrane oxygenation therapy in Australia and New Zealand
Kate R Wilcox, Lane Meredith, Aidan Burrell, Bentley Fulcher, Carol L Hodgson, Alisa M Higgins · 2026
Read Costs and complications of extracorporeal membrane oxygenation therapy in Australia and New Zealand by Kate R Wilcox, Lane Meredith, Aidan Burrell, Bentley Fulcher, Carol L Hodgson, Alisa M Higgins (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13224508.txt.
Description
Kate Wilcox and co-authors costed a life-support therapy in 2026 across Australia and New Zealand. The therapy, called ECMO, pumps blood outside the body through a lung and heart aid for the most grave heart and lung failure. It needs costly gear and expert staff. The team used a shared registry of 1,345 patients who began the therapy from 2019 to 2022, and costed each stay from entry to discharge.
Mean cost swung a great deal by mode. The lung-only mode cost most in all, since those stays ran longest, though its daily cost on the machine was least. More than half of patients had a problem in care, and each added problem raised the bill. Infection raised cost most. Stay length and time in intensive care drove the totals.
Catalog record
| CREATOR | Kate R Wilcox, Lane Meredith, Aidan Burrell, Bentley Fulcher, Carol L Hodgson, Alisa M Higgins |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |